FDA launches program to speed up rare disease drug development
FDA announced on May 10, 2022 that its Center for Drug Evaluation and Research has launched a new program to increase and speed up the development of treatments for unmet needs of patients with rare diseases.
Read the news published by RIS.WORLD on 13 May 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (7 novembre 2022). FDA launches program to speed up rare disease drug development. ELSIBI. Consulté le 12 octobre 2026 à l’adresse https://doi.org/10.58079/o64x
